VNRX (VolitionRx Limited) Stock Analysis - Hedge Fund Holdings
VolitionRx Limited (VNRX) is a publicly traded Healthcare sector company. As of May 21, 2026, VNRX trades at $2.42 with a market cap of $18.44M and a P/E ratio of 0.00. VNRX moved +5.53% today. Year to date, VNRX is -55.55%; over the trailing twelve months it is -74.64%. Its 52-week range spans $1.91 to $18.80. Analyst consensus is buy with an average price target of $40.00. Rallies surfaces VNRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns VNRX stock?
Hedge funds tracked by Rallies that own VNRX include Citadel Advisors and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for VolitionRx Limited.
VNRX Key Metrics
Key financial metrics for VNRX
Metric
Value
Price
$2.42
Market Cap
$18.44M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$18.80
52-Week Low
$1.91
Volume
1.42K
Avg Volume
0
Revenue (TTM)
$2.47M
Net Income
$-24.73M
Gross Margin
0.00%
Top Hedge Funds Holding VNRX
Citadel Advisors holds 68.19K shares of VNRX, changed +68092.00% as of Dec 31, 2024.
Two Sigma holds 48.91K shares of VNRX, changed +115.63% as of Dec 31, 2024.
Hedge funds tracked by Rallies that own VNRX include Citadel Advisors and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for VolitionRx Limited.
Does Rallies show 13F holders for VNRX?
Yes. Rallies tracks hedge fund and 13F ownership data for VNRX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is VNRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VNRX. It does not provide personalized investment advice.
